1-5 of 5
A.H. Jan Danser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial

Marcel H.A. Muskiet, Lennart Tonneijck, Mark M. Smits, Mark H.H. Kramer, D. Margriet Ouwens, Bolette Hartmann, Jens J. Holst, Daan J. Touw, A.H. Jan Danser, Jaap A. Joles, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2020;43(11):2889–2893
https://doi.org/10.2337/dc20-0902
Published: 08 September 2020
View article titled, Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial
Open the PDF for Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial in another window
Journal Articles

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39: 2042–2050

Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A.H. Jan Danser, Piet M. ter Wee, Michaela Diamant, Jaap A. Joles, Daniel H. van Raalte
Journal: Diabetes Care
Diabetes Care 2019;42(3):494
https://doi.org/10.2337/dc19-er03
Published: 23 January 2019
View article titled, Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39: 2042–2050
Open the PDF for Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39: 2042–2050 in another window
Journal Articles

Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A.H. Jan Danser, Piet M. ter Wee, Michaela Diamant, Jaap A. Joles, Daniël H. van Raalte
Journal: Diabetes Care
Diabetes Care 2016;39(11):2042–2050
https://doi.org/10.2337/dc16-1371
Published: 01 September 2016
View article titled, Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Open the PDF for Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Variants in the SIRT1 Gene May Affect Diabetes Risk in Interaction With Prenatal Exposure to Famine

Ilse P.G. Botden, MD, M. Carola Zillikens, MD, Susanne R. de Rooij, PHD, Janneke G. Langendonk, MD, A.H. Jan Danser, PHD, Eric J.G. Sijbrands, MD, Tessa J. Roseboom, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(2):424–426
https://doi.org/10.2337/dc11-1203
Published: 16 January 2012
View article titled, Variants in the <em>SIRT1</em> Gene May Affect Diabetes Risk in Interaction With Prenatal Exposure to Famine
Open the PDF for Variants in the <em>SIRT1</em> Gene May Affect Diabetes Risk in Interaction With Prenatal Exposure to Famine in another window
Journal Articles

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria

Frederik Persson, MD, Peter Rossing, DMSC, Henrik Reinhard, MD, Tina Juhl, Coen D.A. Stehouwer, MD, Casper Schalkwijk, PHD, A.H. Jan Danser, MD, Frans Boomsma, Erik Frandsen, Hans-Henrik Parving, DMSC
Journal: Diabetes Care
Diabetes Care 2009;32(10):1873–1879
https://doi.org/10.2337/dc09-0168
Published: 08 July 2009
View article titled, Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
Open the PDF for Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria in another window
Includes: Supplementary data